Literature DB >> 7995764

Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer.

G E Hanks1, T E Schultheiss, M A Hunt, B Epstein.   

Abstract

PURPOSE: The fundament hypothesis of conformal radiation therapy is that tumor control can be increased by using conformal treatment techniques that allow a higher tumor dose while maintaining an acceptable level of complications. To test this hypothesis, it is necessary first to estimate the incidence of morbidity for both standard and conformal fields. In this study, we examine factors that influence the incidence of acute grade 2 morbidity in patients treated with conformal and standard radiation treatment for prostate cancer. METHODS AND MATERIALS: Two hundred and forty-seven consecutive patients treated with conformal technique are combined with and compared to 162 consecutive patients treated with standard techniques. The conformal technique includes special immobilization by a cast, careful identification of the target volume in three dimensions, localization of the inferior border of the prostate using the retrograde urethrogram, and individually shaped portals that conform to the Planning Target Volume (PTV). Univariate analysis compares differences in the incidence of RTOG-EORTC grade two acute morbidity by technique, T stage, age, irradiated volume, and dose. Multivariate logistic regression includes these same variables.
RESULTS: In nearly all categories, the conformal treatment group experienced significantly fewer acute grade 2 complications than the standard treatment group. Only volume (prostate +/- whole pelvis) and technique (conformal vs. standard) were significantly related to incidence of morbidity on multivariate analysis. When dose is treated as a continuous variable (rather than being dichotomized into two levels), a trend is observed on multivariate analysis, but it does not reach significant levels. The incidence of acute grade 2 morbidity in patients 65 years or older is significantly reduced by use of the conformal technique.
CONCLUSION: The conformal technique is associated with fewer grade 2 acute toxicities for all patients. This conclusion is valid irrespective of selection criteria except in a few cases. Older age is associated with increased toxicity only with the standard technique and not then at a statistically significant level. Elderly patients should not be excluded from external beam radiation because of increased morbidity especially if conformal treatment is available. Volume is not significantly related to morbidity in patients with standard treatment, but it is for conformal treatment. Furthermore, it remains significant in a multivariate analysis that also shows the advantage of conformal treatment. Grade 2 acute toxicities are more volume dependent than dose dependent.

Entities:  

Mesh:

Year:  1995        PMID: 7995764     DOI: 10.1016/0360-3016(94)00366-S

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  Three dimensional conformal photon radiotherapy at a moderate dose level of 66 Gy for prostate carcinoma: early results.

Authors:  S Wachter; N Gerstner; G Goldner; K Dieckmann; A Colotto; R Pötter
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

2.  Radiation therapy as treatment for stage T1c prostate cancers.

Authors:  G E Hanks; A L Hanlon; W H Pinover; T I al-Saleem; T E Schultheiss
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

3.  [A comparison of CT-supported 3D planning with simulator planning in the pelvic irradiation of primary cervical carcinoma].

Authors:  T H Knocke; B Pokrajac; C Fellner; R Pötter
Journal:  Strahlenther Onkol       Date:  1999-02       Impact factor: 3.621

Review 4.  [Locally advanced prostate carcinoma (T2b-T4 N0) without and with clinical evidence of local progression (Tx N+) with lymphatic metastasis. Is radiotherapy for pelvic lymphatic metastasis indicated or not?].

Authors:  T Wiegel; W Hinkelbein
Journal:  Strahlenther Onkol       Date:  1998-05       Impact factor: 3.621

5.  [Comparison of different 3-dimensional irradiation techniques in local radiotherapy of prostatic carcinoma].

Authors:  S Koswig; S Dinges; A Buchali; D Böhmer; J Salk; P Rosenthal; C Harder; L Schlenger; V Budach
Journal:  Strahlenther Onkol       Date:  1999-01       Impact factor: 3.621

6.  Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01.

Authors:  Raymond H Mak; Daniel Hunt; Jason A Efstathiou; Niall M Heney; Christopher U Jones; Himu R Lukka; Jean-Paul Bahary; Malti Patel; Alexander Balogh; Abdenour Nabid; Mark H Leibenhaut; Daniel A Hamstra; Kevin S Roof; Robert Jeffrey Lee; Elizabeth M Gore; Howard M Sandler; William U Shipley
Journal:  Urol Oncol       Date:  2016-07-02       Impact factor: 3.498

7.  [The conformal radiotherapy of localized prostatic carcinoma: acute tolerance and early efficacy].

Authors:  D Zierhut; M Flentje; G Sroka-Perez; V Rudat; R Engenhart-Cabillic; M Wannenmacher
Journal:  Strahlenther Onkol       Date:  1997-02       Impact factor: 4.033

8.  Biological-effective versus conventional dose volume histograms correlated with late genitourinary and gastrointestinal toxicity after external beam radiotherapy for prostate cancer: a matched pair analysis.

Authors:  Ashesh B Jani; Christopher M Hand; Charles A Pelizzari; John C Roeske; Lani Krauz; Srinivasan Vijayakumar
Journal:  BMC Cancer       Date:  2003-05-13       Impact factor: 4.430

9.  Better survival with three-dimensional conformal radiotherapy than with conventional radiotherapy for cervical cancer: a population-based study.

Authors:  Chen-Hsi Hsieh; Shiang-Jiun Tsai; Wen-Yen Chiou; Moon-Sing Lee; Hon-Yi Lin; Shih-Kai Hung
Journal:  ISRN Oncol       Date:  2013-10-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.